|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.44 HKD | -0.36% |
|
-3.13% | -4.24% |
| 01-27 | CanSino Biologics Sees Swing to Profit | MT |
| 01-27 | Cansino Biologics Inc. Provides Earnings Guidance for the Year Ended December 31, 2025 | CI |
| Capitalization | 11.35B 12.85B 1.64B 1.39B 1.26B 1.21B 2.24B 149B 2.32B 14.69B 5.84B 71.76B 6.17B 6.04B 251B | P/E ratio 2025 * |
214x | P/E ratio 2026 * | 33.7x |
|---|---|---|---|---|---|
| Enterprise value | 10.89B 12.34B 1.58B 1.33B 1.21B 1.16B 2.15B 143B 2.23B 14.1B 5.61B 68.9B 5.92B 5.8B 241B | EV / Sales 2025 * |
10.3x | EV / Sales 2026 * | 7.14x |
| Free-Float |
39.2% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -0.36% | ||
| 1 week | -3.13% | ||
| Current month | -5.38% | ||
| 1 month | -10.92% | ||
| 3 months | -24.28% | ||
| 6 months | -31.95% | ||
| Current year | -4.24% |
| 1 week | 33.1 |  | 35.86 |
| 1 month | 33.1 | | 41.64 |
| Current year | 33.1 | | 41.64 |
| 1 year | 25.25 | | 56.55 |
| 3 years | 14.8 | | 72.2 |
| 5 years | 14.8 | | 449.6 |
| 10 years | 14.8 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 13/01/2009 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 13/01/2009 |
Xue Feng Yu
CEO | Chief Executive Officer | 62 | 13/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Shou Bai Chao
BRD | Director/Board Member | 63 | 22/06/2018 |
Xue Feng Yu
CHM | Chairman | 62 | 13/01/2009 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 28/05/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -3.13% | +10.00% | -50.31% | 1.64B | |
| +0.60% | +2.22% | +18.04% | +3.44% | 80.42B | |
| -0.15% | +4.31% | +46.03% | +248.86% | 61.71B | |
| -1.43% | -16.89% | -40.94% | -50.82% | 52.04B | |
| +0.41% | +71.90% | +71.90% | +71.90% | 55.29B | |
| +2.25% | +5.47% | +46.52% | -31.71% | 28.69B | |
| -0.51% | +11.45% | +147.14% | +105.09% | 19.77B | |
| +1.93% | -1.96% | +45.91% | +27.11% | 20.05B | |
| -1.78% | +1.97% | +24.72% | +65.07% | 15.89B | |
| -0.99% | -1.86% | +31.36% | -76.31% | 15.67B | |
| Average | +0.00% | +0.85% | +40.07% | +31.23% | 35.12B | |
| Weighted average by Cap. | +0.10% | +0.14% | +34.74% | +52.48% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.05B 1.19B 153M 129M 117M 112M 208M 13.82B 215M 1.36B 542M 6.66B 572M 560M 23.25B | 1.48B 1.68B 215M 181M 165M 158M 293M 19.46B 303M 1.92B 763M 9.38B 806M 789M 32.75B |
| Net income | 34.55M 39.14M 5.01M 4.22M 3.85M 3.68M 6.83M 454M 7.06M 44.73M 17.79M 219M 18.78M 18.39M 763M | 71M 80.42M 10.29M 8.67M 7.91M 7.55M 14.02M 932M 14.5M 91.91M 36.55M 449M 38.58M 37.79M 1.57B |
| Net Debt | -452M -512M -65.47M -55.17M -50.35M -48.06M -89.24M -5.93B -92.29M -585M -233M -2.86B -246M -240M -9.98B | -767M -869M -111M -93.66M -85.48M -81.59M -152M -10.07B -157M -993M -395M -4.85B -417M -408M -16.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 33.44 $ | -0.36% | 430,946 |
| 12/02/26 | 33.56 $ | -3.06% | 509,000 |
| 11/02/26 | 34.62 $ | -1.48% | 642,015 |
| 10/02/26 | 35.14 $ | +0.86% | 803,600 |
| 09/02/26 | 34.84 $ | +0.93% | 370,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 6185 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition